C2 (Complement Component 2)

Overview

flowchart TD
    C2["C2"] -->|"inhibits"| SIRT2["SIRT2"]
    C2["C2"] -->|"associated with"| TGFB1["TGFB1"]
    C2["C2"] -->|"associated with"| C3["C3"]
    C2["C2"] -->|"associated with"| C5["C5"]
    C2["C2"] -->|"activates"| MAVS["MAVS"]
    C2["C2"] -->|"expressed in"| C6["C6"]
    C2["C2"] -->|"inhibits"| Huntington_s_disease["Huntington's disease"]
    C2["C2"] -->|"associated with"| autism_spectrum_disorder["autism spectrum disorder"]
    C2["C2"] -->|"interacts with"| PI3KC3["PI3KC3"]
    C2["C2"] -->|"participates in"| PI3K_AKT_mTOR_signaling["PI3K-AKT-mTOR signaling"]
    C2["C2"] -->|"participates in"| autophagy_pathway["autophagy pathway"]
    C2["C2"] -->|"activates"| multiple_sclerosis["multiple sclerosis"]
    C2["C2"] -->|"participates in"| NF_kB_signaling["NF-kB signaling"]
    C2["C2"] -->|"participates in"| lipid_metabolism["lipid metabolism"]
    style C2 fill:#4fc3f7,stroke:#333,color:#000

C2 (Complement Component 2) is a crucial protein in the classical complement pathway, representing one of the central activation mechanisms of the complement system—a major component of the innate immune response. Located in the major histocompatibility complex (MHC) class III region on chromosome 6p21.3, the C2 gene encodes a 732-amino acid zymogen that, upon activation, generates the C3 convertase complex essential for complement cascade amplification.

The complement system, discovered in the late 19th century, constitutes a sophisticated network of soluble and membrane-bound proteins that bridge innate and adaptive immunity. C2, alongside its partner C4, forms the enzymatic core of the classical pathway, producing the critical C4b2a complex that cleaves C3 into active fragments. This positioning makes C2 a pivotal regulator of inflammation, opsonization, and cell lysis.

Beyond its fundamental immunological functions, C2 has emerged as a protein of significant interest in neurodegenerative diseases, particularly Alzheimer’s Disease, where complement activation contributes to neuroinflammation, synaptic loss, and disease progression. Additionally, genetic variants in the C2 gene region have been associated with age-related macular degeneration (AMD), highlighting its importance in both ocular and neurological disease contexts.

Gene Structure and Evolution

The C2 gene is located in the MHC class III region of chromosome 6p21.3 (positions 31,900,000-31,950,000, GRCh38) on the minus strand. This region, highly enriched for immune-related genes, also contains C4, factor B (CFB), and various other complement components. The gene spans approximately 18 kb and comprises 18 exons that encode a 732-amino acid protein with a molecular weight of approximately 83 kDa.

Protein Structure

Complement component C2 is synthesized as a single-chain zymogen comprising multiple functional domains:

1. N-terminal domain (aa 1-290): Variable region, heavy chain

2. MCP-like domain (aa 291-450): Protein-protein interactions

3. CCP domains (3) (aa 451-560): Complement control protein modules

4. C-terminal serine protease domain (aa 561-732): Catalytic activity (C2a fragment)

Upon activation, C2 is cleaved to form:

• C2a (heavy chain, aa 1-427): Remains bound to C4b

• C2b (light chain, aa 428-732): Released fragment with catalytic activity

Evolutionary Conservation

C2 shows conservation across vertebrates, reflecting its essential immune function:

The C2/C4 system shows gene duplication in evolution, with distinct but overlapping functions.

Protein Function and Activation

Classical Pathway Activation

The classical complement pathway is initiated by antigen-antibody complexes or pathogen-associated molecular patterns (PAMPs):

Step 1: C1qrs → C1s activation
Step 2: C1s cleaves C4 → C4a + C4b
Step 3: C1s cleaves C2 → C2a + C2b
Step 4: C4b + C2a → C4b2a (C3 convertase)
Step 5: C3 convertase cleaves C3 → C3a + C3b
Step 6: C3b deposition → opsonization, C5 convertase formation

C3 Convertase Function

The C4b2a complex (C3 convertase) represents a critical amplification step:

• Catalytic activity: Rapidly cleaves multiple C3 molecules

• Stability: Relatively short half-life (~2 minutes in plasma)

• Regulation: Controlled by C1-INH, C4BP, factor I

C4b2b Distinction

It is crucial to distinguish the classical pathway C3 convertase from the lectin pathway C3 convertase:

• Classical pathway: C4b2a (C2a fragment)

• Lectin pathway: C4b2b (C2b fragment)

Normal Physiological Functions

Immune Defense

C2 supports fundamental immune functions ^{3Immunobiology (9th ed.)2016Open reference}:

Pathogen Recognition and Elimination

• Opsonization: C3b generated downstream promotes phagocytosis

• Cell lysis: Terminal membrane attack complex (MAC) formation

• Inflammation: C3a and C5a as anaphylatoxins recruit immune cells

Bridge to Adaptive Immunity

• Antigen presentation: C3b enhances antigen uptake by APCs

• B cell activation: Complement receptors on B cells enhance responses

• Immunological memory: C3d as adjuvant for antibody responses

Tissue Homeostasis

Beyond infection, complement participates in:

• Dead cell clearance: Engulfment of apoptotic cells

• Tissue remodeling: Proteolytic cascade in development

• Angiogenesis: Modulation of blood vessel formation

Disease Associations

Alzheimer’s Disease

C2 has significant involvement in Alzheimer’s Disease pathogenesis ^{4Complement in Alzheimer's disease2006 · DOI 10.1016/j.neurobiolaging.2006.04.003Open reference}:

Complement Activation in AD

1. Amyloid-driven activation:

   • β-amyloid plaques activate classical pathway

   • C1q and C1s associated with amyloid deposits

   • C4b and C2b fragments detected in AD brain

2. Neuroinflammation amplification ^{5Complement activation in Alzheimer's disease pathology2019 · DOI 10.1016/j.neurobiolaging.2019.04.020Open reference}:

   • Chronic complement activation drives neuroinflammation

   • Microglial activation by C3a and C5a

   • Cytokine release amplifies pathology

3. Synaptic loss ^{6C2 and C4 as biomarkers in neurodegeneration2017 · DOI 10.1016/j.jneuroim.2017.03.012Open reference}:

   • C1q marks synapses for elimination

   • C3-mediated pruning in development (and pathology)

   • Complement correlates with cognitive decline

4. Gene expression changes [morros2018]:

   • Elevated C2 expression in AD cortex and hippocampus

   • Astrocytic and microglial sources

   • Stage-dependent regulation

Therapeutic Implications

• Complement inhibitors in clinical trials for AD

• C1q blockade to prevent synaptic loss

• C3 inhibition to reduce neuroinflammation

Age-Related Macular Degeneration

As characterized in ^{7Complement C2 variants in age-related macular degeneration2005 · DOI 10.1038/ng209Open reference}, C2 variants influence AMD risk:

Genetic Associations

• C2 E318D variant: Associated with reduced AMD risk

• Haplotype effects: C2-CFB region haplotypes modify risk

• Interaction with CFH: Synergistic effects on disease

Pathogenic Mechanisms

• Complement dysregulation in retina

• Drusen formation involves complement

• Choroidal neovascularization affected

Systemic Lupus Erythematosus

C2 deficiency is strongly associated with SLE ^{8C2 deficiency and autoimmune disease2020 · DOI 10.1016/j.autrev.2020.102573Open reference}:

Clinical Associations

• C2 homozygous deficiency: ~10% develop SLE

• Heterozygous deficiency: Increased risk

• Incomplete penetrance: Not all C2-deficient individuals develop disease

Mechanisms

• Impaired clearance of apoptotic cells

• Reduced classical pathway activity

• Defective immune complex handling

• Increased susceptibility to infections

Other Disease Associations

1. Vasculitis: C2 activation in immune-complex vasculitis

2. Hemolytic disease of the newborn: Anti-C2 antibodies

3. Transplant rejection: Complement-mediated graft damage

Expression Patterns

Tissue Distribution

C2 is expressed in various tissues:

Brain Expression

Within the central nervous system, C2/C2b is expressed in:

• Microglia: Primary source in brain

• Astrocytes: Inflammatory responses

• Neurons: Limited expression

• Endothelial cells: Blood-brain barrier

Subcellular Localization

• Secreted: Primary extracellular location

• Plasma: Circulating in blood (200-400 μg/mL)

• Cell surface: Transient binding during activation

Signaling Pathways

Complement Cascade

C2 sits at a critical junction in the complement system:

Classical Pathway:
C1q → C1rs → C4 → C2 → C4b2a → C3 → C3b → C5 → C5b-9 (MAC)

Alternative Pathway:
Factor B + Factor D + C3b → C3bBb (Alternative C3 convertase)

Lectin Pathway:
Mannose-binding lectin → MASP-1/2 → C4 → C2 → C4b2a → C3

Interaction Networks

C2 participates in several molecular networks:

Inflammatory Signaling

C2 activation triggers downstream inflammatory responses:

• C3a signaling: G-protein coupled receptor activation

• Cell recruitment: Chemotactic effects

• Cytokine production: NF-κB activation in immune cells

Clinical Significance

Diagnostic Markers

C2 and its activation products serve as biomarkers:

Therapeutic Approaches

Current therapeutic strategies include ^{9Complement-targeted therapeutics in disease2021 · DOI 10.1016/j.tips.2021.02.008Open reference}:

1. Complement inhibitors:

   • C1s inhibitors in clinical trials

   • C3 inhibitors (pegcetacoplan)

   • C5 inhibitors (eculizumab, ravulizumab)

2. Gene therapy:

   • AAV-mediated C2 expression

   • CRISPR approaches for deficiency

3. Anti-inflammatory strategies:

   • Downstream complement blockade

   • Receptor antagonists

Research Directions

Unresolved Questions

Key questions remain:

1. Therapeutic window: When to intervene in AD progression

2. Specificity: Targeting complement without compromising immunity

3. Biomarker utility: Clinical utility of C2 measurements

Emerging Areas

• Single-cell analysis: Cell-type specific complement functions

• Structural biology: C2 activation and inhibition complexes

• Systems biology: Complement network modeling

Interactions and Pathways

Protein Interactions

Genetic Interactions

• C4: Paralog with overlapping function

• CFB: Alternative pathway homolog

• C3: Downstream target of C3 convertase

See Also

Related Pathways

• Classical Complement Pathway

• Complement System Overview

• Neuroinflammation

• Innate Immune Signaling

Related Diseases

• Alzheimer’s Disease

• Age-Related Macular Degeneration

• Systemic Lupus Erythematosus

Related Genes

• C4 (Complement Component 4)

• C3 (Complement Component 3

• CFB (Complement Factor B

• C1S (Complement C1s

External Links

• Ensembl: ENSG00000166278

• NCBI Gene: C2

• GeneCards: C2

• UniProt: P06610

• OMIM: 120490

• STRING: C2 Interactions